Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89bd6740714718ac51b7a86296636198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8812676afca6da3e62ef19f3c6303bd8 |
publicationDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1967209-B1 |
titleOfInvention |
Therapeutic agent for prostate cancer |
abstract |
The inventors studied an antitumor effect of an anti-IL-6 receptor antibody on prostate cancer. As a result, it was found that the anti-IL-6 receptor antibody exhibits an antitumor effect on prostate cancer both in vivo and in vitro. Further, it was found that hPM1 exhibits an antitumor effect through IL-6 receptor. |
priorityDate |
2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |